The prevalence of dysplasia and malignant lip lesions in transplant patients

Journal of Oral Pathology and Medicine

Volumn 41, Issue 2, 2012, Pages 113-118

  Nolan, Anita ^a   Girdler, Nick M ^b,c   Seymour, Robin A ^b,c   Mark Thomason, J ^b,c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

HLA typing; Immunosuppression; Lip malignancies; Organ transplant

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; PREDNISOLONE; TACROLIMUS;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CANCER SCREENING; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE DURATION; DYSPLASIA; FEMALE; GRAFT RECIPIENT; HLA MATCHING; HLA TYPING; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIP BIOPSY; LIP CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MOUTH EXAMINATION; PRIORITY JOURNAL; SKIN STRUCTURE; SUNBURN; SUNLIGHT; ULTRAVIOLET RADIATION;

AGE FACTORS; AGED; ALCOHOL DRINKING; CASE-CONTROL STUDIES; ENGLAND; ENVIRONMENTAL EXPOSURE; FEMALE; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIP NEOPLASMS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PRECANCEROUS CONDITIONS; PREVALENCE; RISK FACTORS; SKIN PIGMENTATION; SMOKING; SUNLIGHT; SUNSCREENING AGENTS; TIME FACTORS;

EID: 84856443865     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2011.01072.x     Document Type: Article

References (17)

1. Makitie AA, Lundberg M, Salmela K, et al. Head and neck cancer in renal transplant patients in Finland. Acta Otolaryngol 2008; 128: 1255-8.
2. Villeneuve PJ, Schaubel DE, Fenton SS, et al. Cancer incidence among Canadian kidney transplant recipients. Am J Transplant 2007; 7: 941-8.
3. Regev E, Zeltser R, Lustmann J. Lip carcinoma in renal allograft recipient with long-term immunosuppressive therapy. Oral Surg Oral Med Oral Pathol 1992; 73: 412-4.
4. Thomas DW, Seddon SV, Shepherd JP. Systemic immunosuppression and oral malignancy: a report of a case and review of the literature. Br J Oral Maxillofac Surg 1993; 31: 391-3.
5. De Visscher JG, Bouwes Bavinck JN, Van Der Waal I. Squamous cell carcinoma of the lower lip in renal-transplant recipients. Report of six cases. Int J Oral Maxillofac Surg 1997; 26: 120-3.
6. King GN, Healy CM, Glover MT, et al. Increased prevalence of dysplastic and malignant lip lesions in renal-transplant recipients. N Engl J Med 1995; 332: 1052-7.
7. Van Leeuwen MT, Grulich AE, Mcdonald SP, et al. Immunosuppression and other risk factors for lip cancer after kidney transplantation. Cancer Epidemiol Biomarkers Prev 2009; 18: 561-9.
8. Bouwes Bavinck JN, Kootte AM, Van Der Woude FJ, et al. On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients. J Invest Dermatol 1991; 97: 269-72.
9. Bouwes Bavinck JN, Vermeer BJ, Van Der Woude FJ, et al. Relation between skin cancer and HLA antigens in renal-transplant recipients. N Engl J Med 1991; 325: 843-8.
10. Terasaki PI, Mcclelland JD. Microdroplet assay of human serum cytotoxins. Nature 1964; 204: 998-1000.
11. Ollerup O, Zetterquist H. HLA-DR typing by polymerase chain reaction amplification with sequence specific primers (PCR-SSP). In: Hui KBJ ed. Handbook of HLA typing technique. Boca Ranton: CRC Press, 1993.
12. Takemoto S, Gjertson D, Terasaki PI. HLA matching: a comparison of conventional and molecular approaches. In: Terasaki P, Cecka J, eds. Clinical transplants. Los Angeles: UCLA Tissue Typing Laboratory, 1992; 413 pp.
13. Rodey GE, Neylan JF, Whelchel JD, et al. Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients. Hum Immunol 1994; 39: 272-80.
14. Park MS, Lau M, Geer LI, Terasaki PI. International sera exchange analyses in relation to DNA sequences: summary report from 1990 to 1994. In: Terasaki PI, Cecka J, eds. Clinical transplants. Los Angeles: UCLA Tissue Typing Laboratory, 1994.
15. Espana A, Redondo P, Fernandez AL, et al. Skin cancer in heart transplant recipients. J Am Acad Dermatol 1995; 32: 458-65.
16. Bouwes Bavinck JN, Claas FH, Hardie DR, et al. Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia. J Invest Dermatol 1997; 108: 708-11.
17. Gaya SB, Rees AJ, Lechler RI, et al. Malignant disease in patients with long-term renal transplants. Transplantation 1995; 59: 1705-9.